Earth Alive Clean Technologies Inc. (EACTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.36 Million | -1.96 Million | -1.25 Million | -1.41 Million | -1.81 Million | -1.77 Million |
| Net Income | -3.37 Million | -3.03 Million | -1.84 Million | -1.11 Million | -2.05 Million | -2.57 Million |
| Depreciation & Amortization | 175.98 Thousand | 60.36 Thousand | 21.87 Thousand | 27.4 Thousand | 32.33 Thousand | 26.23 Thousand |
| Deferred income taxes | - | 442.71 Thousand | -558.97 Thousand | -820.7 Thousand | 77.07 Thousand | -33.19 Thousand |
| Stock-based compensation | 21.96 Thousand | 73.62 Thousand | 601.73 Thousand | 224.65 Thousand | 177.53 Thousand | 711.36 Thousand |
| Change in working capital | -328.63 Thousand | 608.37 Thousand | 84.98 Thousand | -503.42 Thousand | 330.75 Thousand | 42.26 Thousand |
| Other non-cash items | 814.93 Thousand | -116.67 Thousand | 432.97 Thousand | 772.38 Thousand | -376.21 Thousand | 746.95 Thousand |
| Investing Cash Flow | 4.33 Million | -4.81 Million | -3148.96 | - | - | -144.11 Thousand |
| Investments in PPE | -189.01 Thousand | -387.2 Thousand | -3148.96 | - | - | -144.11 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -4.42 Million | - | - | - | - |
| Sales/Maturities of investments | 4.52 Million | - | - | - | - | - |
| Other Investing Activities | 4.52 Million | -4.43 Million | - | - | - | - |
| Financing Cash Flow | 2.38 Million | 4.41 Million | 3.91 Million | 47.29 Thousand | 3.49 Million | 1.21 Million |
| Debt repayment | -256.29 Thousand | -63.7 Thousand | - | -60 Thousand | - | -724.23 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.58 Million | 4.46 Million | 3.91 Million | 47.29 Thousand | 3.49 Million | 492.07 Thousand |
| Other Financing Activities | -30.17 Thousand | 16.7 Thousand | 3.91 Million | 196.48 | 3.49 Million | 492.36 Thousand |
| Accounts receivables | 437.18 Thousand | -286.78 Thousand | 56.95 Thousand | -221.65 Thousand | 47.76 Thousand | -151.58 Thousand |
| Accounts payables | -682.9 Thousand | 725.94 Thousand | 242.4 Thousand | -258.84 Thousand | 325.36 Thousand | 271.36 Thousand |
| Inventory | -54.4 Thousand | 197.9 Thousand | -212.85 Thousand | -60.72 Thousand | -53.84 Thousand | -58.13 Thousand |
| Other working capital | -28.5 Thousand | -28.68 Thousand | -1524.00 | 37.8 Thousand | 11.46 Thousand | -19.37 Thousand |
| Cash at beginning of period | 520.94 Thousand | 3.09 Million | 443.51 Thousand | 1.77 Million | 82.64 Thousand | 861.36 Thousand |
| Cash at end of period | 3.89 Million | 520.94 Thousand | 3.09 Million | 443.51 Thousand | 1.77 Million | 82.64 Thousand |
| Capital Expenditure | -189.01 Thousand | -387.2 Thousand | -3148.96 | - | - | -144.11 Thousand |
| Effect of forex changes on cash | - | -1.15 | -0.87 | - | - | - |
| Net cash flow / Change in cash | 3.37 Million | -2.57 Million | 2.65 Million | -1.33 Million | 1.69 Million | -778.72 Thousand |
| Free Cash Flow | -3.55 Million | -2.35 Million | -1.26 Million | -1.41 Million | -1.81 Million | -1.92 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -984.44 Thousand | -3.37 Million | -1.12 Million | -666.57 Thousand | -614.16 Thousand | -933.77 Thousand |
| Depreciation & Amortization | 45.28 Thousand | 175.98 Thousand | 43.44 Thousand | 44.81 Thousand | 92.56 Thousand | 44.31 Thousand |
| Deferred income taxes | - | - | - | -424.36 Thousand | -189.01 Thousand | -92.69 Thousand |
| Stock-based compensation | 8005.00 | 21.96 Thousand | 14.8 Thousand | -797.00 | 3887.00 | 4063.00 |
| Change in working capital | -1.49 Million | -328.63 Thousand | 689.47 Thousand | -318.23 Thousand | -123.4 Thousand | -557.12 Thousand |
| Other non-cash items | 1.6 Million | 814.93 Thousand | -563.2 Thousand | 433.71 Thousand | 198.14 Thousand | 101.95 Thousand |
| Investing Cash Flow | -2.81 Million | 4.33 Million | 3.11 Million | -147.53 Thousand | -131.92 Thousand | 1.47 Million |
| Investments in PPE | -15.61 Thousand | -189.01 Thousand | -28.26 Thousand | -22.5 Thousand | -131.92 Thousand | -5629.05 |
| Acquisitions | -2.79 Million | - | - | - | - | - |
| Investment purchases | - | - | 3.14 Million | -3.06 Million | - | - |
| Sales/Maturities of investments | - | 4.52 Million | - | 2.94 Million | - | 1.47 Million |
| Other Investing Activities | 1.00 | 4.52 Million | 3.14 Million | -125.05 Thousand | - | -0.95 |
| Financing Cash Flow | 2.9 Million | 2.38 Million | -82.24 Thousand | -40.12 Thousand | 2.55 Million | -40.08 Thousand |
| Debt repayment | -2.73 Million | -256.29 Thousand | -93.36 Thousand | -54.51 Thousand | -54.2 Thousand | -54.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 885.84 Thousand | 2.58 Million | -11.79 Thousand | - | 2.59 Million | - |
| Other Financing Activities | 2.05 Million | -30.17 Thousand | -30.17 Thousand | 14.38 Thousand | 13.31 Thousand | 14.12 Thousand |
| Accounts receivables | -697.77 Thousand | 437.18 Thousand | 513.3 Thousand | -124.2 Thousand | -13.52 Thousand | 63.45 Thousand |
| Accounts payables | 173.27 Thousand | -682.9 Thousand | 181.29 Thousand | -213.75 Thousand | - | - |
| Inventory | -972.19 Thousand | -54.4 Thousand | 31.92 Thousand | 2412.94 | -26.3 Thousand | -61.3 Thousand |
| Other working capital | 5485.56 | -28.5 Thousand | -37.04 Thousand | 17.3 Thousand | 8247.72 | -17.11 Thousand |
| Cash at beginning of period | 3.89 Million | 520.94 Thousand | 1.14 Million | 2.31 Million | 521.97 Thousand | 520.94 Thousand |
| Cash at end of period | 1.48 Million | 3.89 Million | 3.89 Million | 1.14 Million | 2.31 Million | 521.97 Thousand |
| Capital Expenditure | -15.61 Thousand | -189.01 Thousand | -28.26 Thousand | -22.5 Thousand | -131.92 Thousand | -5629.05 |
| Effect of forex changes on cash | - | - | - | -1.23 | -0.79 | -0.24 |
| Net cash flow / Change in cash | -2.4 Million | 3.37 Million | 2.74 Million | -1.17 Million | 1.79 Million | 1025.00 |
| Free Cash Flow | -2.43 Million | -3.55 Million | -344.85 Thousand | -953.95 Thousand | -763.9 Thousand | -1.43 Million |
SRS
LB
ITERA
CHMI-PA
SGQRF
PHARM